Crinetics Pharmaceuticals (CRNX) Earnings Date & Reports

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CRNX is expected to report earnings to -122 cents per share on August 11

Crinetics Pharmaceuticals CRNX Stock Earnings Reports

Q2'26

Est.

$-1.22

Q1'26

Beat

by $0.05

Q4'25

Beat

by $0.05

Q3'25

Missed

by $0.13

Q2'25

Missed

by $0.13

The last earnings report on May 07 showed earnings per share of -123 cents, beating the estimate of -127 cents. With 103.11K shares outstanding, the current market capitalization sits at 3.73B.

View a ticker or compare two or three

Compare

CRNX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CRNX